Viewing Study NCT05734495


Ignite Creation Date: 2025-12-24 @ 1:33 PM
Ignite Modification Date: 2025-12-29 @ 9:43 PM
Study NCT ID: NCT05734495
Status: RECRUITING
Last Update Posted: 2025-05-11
First Post: 2023-02-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Pirtobrutinib and Venetoclax in Waldenström Macroglobulinemia
Sponsor: Dana-Farber Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module